Advertisement
Advertisement
U.S. markets close in 1 hour
Advertisement
Advertisement
Advertisement
Advertisement

Heart Test Laboratories, Inc. (HSCS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.3108-0.0592 (-4.32%)
As of 02:29PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close1.3700
Open1.3500
Bid1.3000 x 2200
Ask1.3400 x 1200
Day's Range1.2400 - 1.4200
52 Week Range1.1400 - 6.0000
Volume38,059
Avg. Volume85,561
Market Cap10.752M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.0940
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for HSCS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Heart Test Laboratories, Inc.
    Daily – Vickers Top Insider Picks for 12/07/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • GlobeNewswire

    HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms

    Southlake, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced that it has entered into a multi-year collaboration agreement with Rutgers University (Rutgers), one of America’s leading public research universit

  • GlobeNewswire

    HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022

    Southlake, Texas, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of AI, today announced that Andrew Simpson, Chief Executive Officer of HeartSciences, will be presenting at the 2022 RHK Disruptive Growth Conference being held December 5-6, 2022 at the offices o

  • GlobeNewswire

    HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022

    Southlake, Texas, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of AI, today announced that Andrew Simpson, Chief Executive Officer of HeartSciences, will be participating at the at the 11th Annual Benchmark Discovery One-on-One Investor Conference which is be

Advertisement
Advertisement